Passport Capital’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Passport Capital’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-8,151	Closed	-$352K	–	165
2015 Q3	$352K	Buy	+8,151	New	+$344K	0.01%	128

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Passport Capital's WX Position: Q4 2015 in Review

Passport Capital sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 8,151 shares — an estimated $352K sold.

Passport Capital first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $352K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Passport Capital reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Passport Capital sold 8,151 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $352K.
Passport Capital first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
Passport Capital's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $352K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Passport Capital's 13F filing for Q4 2015, filed 16 Feb 2016.